Ainos Inc AIMD 深 滬
等待開盤 11-07 09:30:00 美东时间
2.915
-0.345
-10.58%
華盛通- 最 高3.2122
- 今 開3.19
- 成交量 4.10万股
- 最 低 2.90
- 昨 收 3.26
- 總市值 1221.97万
- 52周最高 5.00
- 市盈率 靜 --
- 換手率 0.98%
- 52周最低 2.055
- 委 比 86.41%
- 總股本 419.20万
- 歷史最高 93.75
- 量 比 1.75
- 振 幅 9.58%
- 歷史最低 2.00
- 每 手 1
- 風險率 0.54%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Ainos Collaborates With NEXCOM International To Integrate Ainos' AI Nose Technology With NEXCOM's Industrial Edge Computing Platforms
SAN DIEGO, CALIFORNIA / ACCESS Newswire / October 14, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW), a leader in AI-powered scent digitization, today announced a strategic partnership with NEXCOM International Co.,
10-14 20:33
Ainos Secures Seven New Patents In Europe, Germany, Taiwan, And China, Enhancing Its AI Nose Digital Olfaction Platform For Robotics Applications
Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent digitization, today announced it has secured seven new patents in Europe, Germany, Taiwan and China that strengthen its AI
09-30 20:32
Ainos Files Prospectus for Additional Share Offering
Ainos ( ($AIMD) ) has provided an announcement. Ainos, Inc. entered into an At ...
09-08 21:29
Ainos Launches Patented AI Nose Platform For Industrial And Healthcare Markets, Unveils SmellTech-As-A-Service At Automation Taipei 2025
Patented AI Olfaction Platform Targets Semiconductor, Smart Factory, and Hospital Markets With First Deployments UnderwaySmellTech-as-a-Service Subscription Delivers AI Upgrades and Analytics, Keeping Enterprises Ahead
08-14 21:39
Ainos Q2 EPS $(0.99) Up From $(2.45) YoY, Sales $4.663K
Ainos (NASDAQ:AIMD) reported quarterly losses of $(0.99) per share. This is a 59.59 percent increase over losses of $(2.45) per share from the same period last year. The company reported $4.663 thousand in sales this
08-14 04:20
Ainos, Inc Announces Its Investigational Low-Dose Oral Interferon-Alpha Drug Candidate, Veldona Has Received Formal Approval From Taiwan's Food And Drug Administration To Initiate A Clinical Study For Primary Sjögren's Syndrome
Advancing a Novel, Side-Effect-Free Treatment for a Rare Yet Widely Underserved Autoimmune DiseaseAinos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a Texas incorporated, dual-platform AI and biotech
08-04 20:04
Ainos Regains Nasdaq Compliance, Accelerates AI Nose Platform Commercialization With 90-Day Execution Plan
Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer in AI-powered scent digitization, today announced it has regained compliance with the minimum bid price requirement for continued listing on
07-16 20:09
Ainos shares are trading higher after the company completed its 1-for-5 stock consolidation.
Ainos shares are trading higher after the company completed its 1-for-5 stock c...
07-01 00:49
Ainos To Implement Consolidation Of Its Common Stock, Effective June 30, 2025
Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that it will implement a consolidation of its common stock ("stock consolidation"), effective at the opening of trading on June 30, 2025.
06-26 23:02
Ainos Partners with Kenmec for AI Integration
Ainos ( ($AIMD) ) just unveiled an update. On June 24, 2025, Ainos, Inc. announ...
06-24 20:28
